e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
New insights into reactive oxygen species
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of pulse therapy with glucocorticoid and cyclophosphamide on lung fibrosis due to paraquat poisoning in rat
S. Seifirad, N. Hasanzadeh Ghavifekr, A. Ghaffari, E. Mostafidi, S. Talghini (Islamic Republic Of Iran)
Source:
Annual Congress 2010 - New insights into reactive oxygen species
Session:
New insights into reactive oxygen species
Session type:
E-Communication Session
Number:
3730
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Seifirad, N. Hasanzadeh Ghavifekr, A. Ghaffari, E. Mostafidi, S. Talghini (Islamic Republic Of Iran). Effect of pulse therapy with glucocorticoid and cyclophosphamide on lung fibrosis due to paraquat poisoning in rat. Eur Respir J 2010; 36: Suppl. 54, 3730
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Effects of prednisolone and imatinib mesylate on inflammation and fibrosis in amiodarone-induced pulmonary toxicity in rats
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Effects of therapy by low-dose surfactant enriched with dextran in newborn rabbits with acute lung injury
Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research
Year: 2004
Effect of administration of purified fish oil on bleomycin induced lung fibrosis in rats
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Therapeutic effectiveness of early and late surfactant-BL administration in bleomycine induced injury of lung in rats
Source: Eur Respir J 2003; 22: Suppl. 45, 532s
Year: 2003
The effect of smoking to oxidative stress on lung tissue of rats with inhaled and intratracheal bleomycin induced pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation
Year: 2007
Effects of budesonide and N-acetylcysteine on acute lung injury induced by intratracheal endotoxin
Source: Eur Respir J 2003; 22: Suppl. 45, 461s
Year: 2003
Treatment of chemical-induced lung injury by dexamethasone and liposome-incorporated vitamin E
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
High pulse dose steroids in Severe COVID-19 pneumonitis refractory hypoxemia to dexamethasone
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 140s
Year: 2003
Effects of basiliximab and triple therapy on airway mucociliary clearance of rats
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
G-CSF administration improves chronic lung disease caused by exposure to high-concentration oxygen in neonatal mice
Source: Annual Congress 2012 - Issues in neonatal and paediatric intensive care
Year: 2012
Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004
Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Source: Eur Respir J 2009; 33: 634-645
Year: 2009
Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
The effects of erdosteine and N-acetylcysteine treatment following lung injury on the regulation of apoptosis of capillary endothelial cells in the model of experimental pulmonary fibrosis induced by bleomycin
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept